{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-021359","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.090593+00:00","generated_at":"2026-05-23T00:01:25.415140+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Ocugen presents clinical trial data at Eyecelerator conference","bullets":["Presentation furnished as Exhibit 99.1; used at May 2, 2025 Eyecelerator showcase.","Data shows mean change in BCVA and visual field responder proportions.","Specific numerical results not fully extractable due to formatting in filing text.","No new financial results, guidance, or corporate updates provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-021359","json":"https://secwatch.observer/filing/0001628280-25-021359.json","markdown":"https://secwatch.observer/filing/0001628280-25-021359.md","text":"https://secwatch.observer/filing/0001628280-25-021359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/0001628280-25-021359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/ocgn-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T00:01:25.415140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}